CLINICAL TRIALS PROFILE FOR ESTRACE
✉ Email this page to a colleague
All Clinical Trials for ESTRACE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00114517 ↗ | ELITE: Early Versus Late Intervention Trial With Estradiol | Completed | National Institute on Aging (NIA) | Phase 2/Phase 3 | 2004-07-01 | The purpose of this study is to examine the effects of oral 17B-estradiol (estrogen) on the progression of early (subclinical) atherosclerosis and cognitive decline in healthy postmenopausal women. |
NCT00114517 ↗ | ELITE: Early Versus Late Intervention Trial With Estradiol | Completed | University of Southern California | Phase 2/Phase 3 | 2004-07-01 | The purpose of this study is to examine the effects of oral 17B-estradiol (estrogen) on the progression of early (subclinical) atherosclerosis and cognitive decline in healthy postmenopausal women. |
NCT00115024 ↗ | EPAT: Estrogen in the Prevention of Atherosclerosis Trial | Completed | Mead Johnson Nutrition | Phase 2/Phase 3 | 1994-04-01 | The purpose of this study is to determine the effects of estrogen replacement therapy (ERT) on the progression of early atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease (CVD). |
NCT00115024 ↗ | EPAT: Estrogen in the Prevention of Atherosclerosis Trial | Completed | National Institute on Aging (NIA) | Phase 2/Phase 3 | 1994-04-01 | The purpose of this study is to determine the effects of estrogen replacement therapy (ERT) on the progression of early atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease (CVD). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ESTRACE
Condition Name
Clinical Trial Locations for ESTRACE
Trials by Country
Clinical Trial Progress for ESTRACE
Clinical Trial Phase
Clinical Trial Sponsors for ESTRACE
Sponsor Name